Price
$20.74
Decreased by -2.95%
Dollar volume (20D)
7.84 M
ADR%
8.49
Shares float
26.57 M
Shares short
6.54 M [24.60%]
Shares outstanding
49.07 M
Market cap
1.05 B
Beta
0.95
Price/earnings
N/A
20D range
15.81 22.64
50D range
13.30 22.64
200D range
13.30 30.03

Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer.

The company's lead product candidates comprise ELVN-001, a small molecule kinase inhibitor which is in Phase 1 clinical trial to treat adults with chronic myeloid leukemia; and ELVN-002, a CNS penetrant and irreversible HER2 inhibitor that is in Phase 1 clinical trial for the treatment of non-small cell lung cancer (NSCLC) and other HER2 driven cancers and solid tumors.

The company is headquartered in Boulder, Colorado.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
May 12, 25 -0.57
Decreased by -5.56%
-0.50
Decreased by -13.03%
Mar 12, 25 -0.46
Increased by +2.13%
-0.52
Increased by +11.11%
Nov 7, 24 -0.48
Increased by +6.24%
-0.50
Increased by +4.36%
Aug 13, 24 -0.41
Increased by 0.00%
-0.55
Increased by +25.45%
May 14, 24 -0.54
Increased by +32.50%
-0.57
Increased by +5.26%
Mar 14, 24 -0.47
Decreased by -138.84%
-0.54
Increased by +12.96%
Nov 9, 23 -0.51
Increased by +29.17%
-0.47
Decreased by -8.51%
Aug 10, 23 -0.41
Increased by +76.70%
-0.36
Decreased by -13.89%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Mar 31, 25 0.00
Decreased by N/A%
-28.54 M
Decreased by -25.53%
Decreased by N/A%
Decreased by N/A%
Dec 31, 24 0.00
Decreased by -100.00%
-23.18 M
Decreased by -19.67%
Decreased by N/A%
Decreased by N/A%
Sep 30, 24 0.00
Decreased by N/A%
-23.16 M
Decreased by -11.49%
Decreased by N/A%
Decreased by N/A%
Jun 30, 24 0.00
Decreased by N/A%
-19.95 M
Decreased by -19.31%
Decreased by N/A%
Decreased by N/A%
Mar 31, 24 0.00
Decreased by N/A%
-22.74 M
Decreased by -74.50%
Decreased by N/A%
Decreased by N/A%
Dec 31, 23 440.00 K
Increased by +N/A%
-19.37 M
Decreased by -160.18%
Decreased by -4.40 K%
Decreased by N/A%
Sep 30, 23 0.00
Decreased by N/A%
-20.77 M
Decreased by -96.79%
Decreased by N/A%
Decreased by N/A%
Jun 30, 23 0.00
Decreased by N/A%
-16.72 M
Decreased by -88.11%
Decreased by N/A%
Decreased by N/A%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY